Post COVID-19 Guillain–Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure

References

1. 1.↵
   1. Reichard RR,
   2. Kashani KB,
   3. Boire NA,
   4. Constantopoulos E,
   5. Guo Y,
   6. Lucchinetti CF.

   Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta neuropathologica 2020; 140: 1–6.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Uncini A,
   2. Yuki N.

   Sensory Guillain–Barré syndrome and related disorders: an attempt at systematization. Muscle & nerve 2012; 45: 464–470.

   OpenUrlPubMed
3. 3.↵
   1. Leonhard SE,
   2. Mandarakas MR,
   3. Gondim FA,
   4. Bateman K,
   5. Ferreira ML,
   6. Cornblath DR, et al.

   Diagnosis and management of Guillain–Barré syndrome in ten steps. Nature Reviews Neurology 2019; 15: 671–683.

   OpenUrl
4. 4.↵
   1. Van den Bergh PY,
   2. Piéret F,
   3. Woodard JL,
   4. Attarian S,
   5. Grapperon AM,
   6. Nicolas G, et al.

   Guillain-Barre syndrome subtype diagnosis: a prospective multicentric European study. Muscle Nerve 2018; 58: 23–28.

   OpenUrl
5. 5.↵
   1. Asbury AK.

   Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol 1981; 9: 1–5.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Semproni M,
   2. Gibson G,
   3. Kuyper L,
   4. Tam P.

   Unusual sensory variant of Guillain-Barré syndrome. BMJ Case Rep 2017; 2017: bcr2016218935.
7. 7.↵
   1. Österlund-Tauriala E,
   2. Partanen JV.

   Three cases of acute distal demyelinating neuropathy with recovery. Clinical Case Reports 2017; 5: 822.

   OpenUrl
8. 8.↵
   1. Uncini A,
   2. Kuwabara S.

   The electrodiagnosis of Guillain-Barré syndrome subtypes: where do we stand? Clinical Neurophysiology 2018; 129: 2586–2593.

   OpenUrl
9. 9.↵
   1. Almutairi A,
   2. Abdulqader SB,
   3. Alhameed M,
   4. Ali S,
   5. Alosaimi B.

   Guillain-BarrE syndrome following COVID-19: a case report. Journal of Research in Medical and Dental Science 2021; 9: 7–10.

   OpenUrl
10. 10.↵
    1. Moody R,
    2. Wilson K,
    3. Flanagan KL,
    4. Jaworowski A,
    5. Plebanski M.

    Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Int J Mol Sci 2021; 22: 8965.

    OpenUrl